about us. We are dedicated to realizing the potential of natural killer (NK) cells for the treatment of cancer. Our proprietary technology is designed to harness the power of these important …

Nkarta's two lead programs are NKX101: Engineered to target NKG2D ligands and NKX019: Engineered to target CD19

2022年4月29日 · 美国时间4月25日，Nkarta Therapeutic（后称：Nkarta）公布了公司两款CAR-NK在研管线NKX101（靶向NKG2D）和NKX019（靶向CD19）治疗血液瘤的最新临床数据。

In this episode of Nkata Podcast: Art & Processes, host Emeka Okereke engages in a compelling conversation with Nigerian painter, designer, and multimedia artist Ibe Ananaba. A lifelong …

2020年12月5日 · Nkarta：CAR-NK细胞治疗领域中又一新星 作者：蹊之美股生物医药

2022年4月26日 · 药明康德内容团队编辑今日，Nkarta公司宣布，该公司的两款主打嵌合抗原受体（CAR）自然杀伤（NK）细胞候选疗法NKX101和NKX019，在治疗不同血液癌症 ...

NK cells are the cornerstone of innate immune surveillance. Allogeneic cell source that can be scaled for off-the-shelf production; Proprietary expansion, persistence, cryopreservation and …

EP14: “Move one foot in front of the other, and you will find your road”. Nkata with Jide Adeniyi-Jones

2023年2月8日 · NKATA is an Igbo word from the language spoken by the Igbo people of Nigeria. It simply means "Conversation". Thus this podcast series will feature conversations with …

This essay emerged out of ongoing conversations with Chicago-based artist, Nnenna Okore, as she conceptualized and began to fabricate the work for her KAM installation, Nkata. Thus …